https://itsupport.concertai.com/testing-dynamic-2/mp51-18-population-based-trends-and-outcomes-for-cytoreductive-nephrectomy-for-metastatic-renal-cell-carcinoma-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-us-based-retrospective-observational-study-of-biomarker-testing-patterns-across-lines-of-therapy-in-patients-with-metastatic-colorectal-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/use-of-a-validated-assessment-tool-demonstrates-the-frequency-of-patient-experienced-regimen-related-side-effects-associated-with-the-treatment-of-common-solid-tumors2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-in-brca-positive-metastatic-breast-cancer-patients-treated-in-the-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-characteristics-and-treatment-of-patients-with-small-cell-prostate-cancer-analysis-of-a-real-world-cohort-from-an-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comparison-of-dna-sequencing-immunohistochemistry-and-in-situ-hybridization-techniques-to-determine-her2-status-in-metastatic-breast-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-overall-survival-in-her2-plus-metastatic-breast-cancer-at-us-community-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-survival-benefit-of-adjuvant-trastuzumab-with-or-without-chemotherapy-in-the-management-of-small-t1mic-t1a-t1b-t1c-node-negative-her2-plus-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/3395-15-investigating-clinical-features-and-molecular-mechanisms-of-long-term-response-and-acquired-resistance-to-immunotherapy-in-non-small-cell-lung-cancer-by2026-07-07https://itsupport.concertai.com/testing-dynamic-2/summary-of-the-12-most-common-cancers-in-the-cancerlinq-discovery-clqd-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-outcomes-in-patients-with-metastatic-neuroendocrine-tumors-retrospective-analysis-of-a-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-impact-of-treatment-induced-peripheral-neuropathy-of-patient-reported-outcomes-in-patients-with-multiple-myeloma-in-the-united-states-20152026-07-07https://itsupport.concertai.com/testing-dynamic-2/annual-trends-in-opioid-prescribing-for-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc-cancerlinq-data-analysis-2010-to-20172026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-use-of-bevacizumab-awwb-a-bevacizumab-biosimilar-in-us-patients-with-metastatic-colorectal-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/impacts-of-time-spent-on-rituximab-infusion-on-patient-satisfaction-stress-employment-and-caregiver-burden2026-07-07https://itsupport.concertai.com/testing-dynamic-2/113p-real-world-treatment-options-for-metastatic-nsclc-patients-following-progression-on-chemo-immunotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-effectiveness-in-a-rare-oncology-indication-lessons-from-an-external-control-cohort-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-in-patients-with-unresected-stage-iii-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/streamline-retrospective-cohort-study-of-relapsed-or-refractory-r-r-flt3-mutated-acute-myeloid-leukemia-aml-real-world-treatment-testing-patterns-and-outcomes2026-07-07https://itsupport.concertai.com/testing-dynamic-2/cancer-patient-preferences-and-willingness-to-pay-for-preventing-chemotherapy-induced-nausea-and-vomiting-in-the-u-s2026-07-07https://itsupport.concertai.com/testing-dynamic-2/prognostic-impact-of-second-primary-malignancies-in-multiple-myeloma-an-asco-cancerlinq-discovery-analysis-of-the-modern-era2026-07-07https://itsupport.concertai.com/testing-dynamic-2/incidence-of-severe-acute-respiratory-syndrome-coronavirus-2-and-subsequent-mortality-in-a-multisite-cohort-of-patients-with-cancer-in-the-cancerlinq-discovery-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-in-patients-with-relapsed-refractory-multiple-myeloma-receiving-greater-than-or-equal-to-3-lines-of-therapy-a-real-world-evaluation-in2026-07-07https://itsupport.concertai.com/testing-dynamic-2/artificial-intelligence-model-to-predict-slow-progression-for-advanced-non-small-cell-lung-cancer-ansclc-patients-receiving-second-line-therapies2026-07-07https://itsupport.concertai.com/testing-dynamic-2/outcomes-among-metastatic-breast-cancer-patients-with-characteristics-that-confer-a-less-favorable-prognosis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-baseline-treatment-patterns-and-overall-survival-rwos-in-patients-pts-with-metastatic-castration-resistant-prostate-cancer-mcrpc-treated-with-olaparib-in-the2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-clinical-outcomes-among-cholangiocarcinoma-patients-treated-with-futibatinib-or-pemigatinib2026-07-07https://itsupport.concertai.com/testing-dynamic-2/7857-9-multi-modal-real-world-data-uncovers-predictors-of-clinical-response-to-top1i-and-optimizes-adc-strategies-in-colorectal-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/variation-of-hormonal-agent-usage-with-postoperative-radiation-therapy-results-from-a-population-based-cohort-of-prostate-cancer-patients-in-community-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-with-adjuvant-nonsteroidal-aromatase-inhibitors-nsais-vs-tamoxifen-tam-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-and-utilization-outcomes-associated-with-tumor-mutational-burden-in-a-real-world-pan-tumor-population2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-use-and-outcomes-of-androgen-receptor-pathway-inhibitors-triplet-therapy-for-metastatic-hormone-sensitive-prostate-cancer-araat2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-associated-with-sequential-and-non-sequential-use-of-cdk4-and-6-inhibitors-in-patients-with-hr-plus-her2-mbc-in-the-real-world2026-07-07https://itsupport.concertai.com/testing-dynamic-2/656p-real-world-rw-frontline-1l-treatments-txs-in-patients-pts-with-advanced-non-small-cell-lung-cancer-nsclc-harboring-epidermal-growth-factor-receptor-efgr-exon-202026-07-07https://itsupport.concertai.com/testing-dynamic-2/pp01-58-real-world-outcomes-in-patients-with-egfr-wildtype-non-squamous-locally-advanced-metastatic-nsclc-receiving-second-or-third-line-docetaxel-pooled-analysis-from2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-among-patients-diagnosed-with-metastatic-castration-sensitive-prostate-cancer-in-community-oncology-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/representativeness-of-race-ethnicity-and-social-determinants-of-health-in-patients-with-advanced-non-small-cell-lung-cancer-via-linkage-of-real-world-electronic-health2026-07-07https://itsupport.concertai.com/testing-dynamic-2/uptake-and-efficacy-of-immuno-oncology-combinations-in-metastatic-renal-cell-carcinoma-in-the-united-states-evidence-from-the-asco-cancerlinq-discovery-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/p1-09-09-disparities-in-second-breast-cancer-events-and-survival-persist-despite-optimal-treatment-in-hormone-receptor-positive-breast-cancer-analysis-of-the-real-world2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-among-locally-advanced-cervical-cancer-patients-receiving-concurrent-chemoradiotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/msr69-developing-an-ehr-based-multifeature-machine-learning-model-to-identify-lung-cancer-subtype2026-07-07https://itsupport.concertai.com/testing-dynamic-2/understanding-health-related-quality-of-life-hrqol-in-unresected-stage-iii-non-small-cell-lung-cancer-nsclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/2796ep-seizure-related-6-homolog-sez6-expression-pattern-and-prognostic-impact-in-a-real-world-cohort-of-patients-with-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/healthcare-resource-utilization-and-cost-in-patients-with-relapsed-refractory-classical-hodgkins-lymphoma-who-received-autologous-stem-cell-transplantation-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/developing-a-digital-twin-framework-for-colorectal-cancer-outcome-prediction-and-robust-clinical-trial-simulation2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-survival-by-race-among-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc-in-the-united-states-a-us-electronic-medical-record2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-analysis-of-a-large-electronic-medical-record-database-of-patients-with-higher-risk-myelodysplastic-syndromes-hr-mds-treatment-profiles-clinical2026-07-07https://itsupport.concertai.com/testing-dynamic-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhitelogonewwhitelogonewhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcerAI%20Logo%20(Web).svgConcerAILogoWebConcerAILogoWeb2026-07-07https://itsupport.concertai.com/testing-dynamic-2/burden-of-symptoms-associated-with-development-of-metastatic-bone-disease-in-patients-with-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-of-adjuvant-endocrine-therapy-and-ovarian-suppression-in-premenopausal-hr-plus-her2-plus-breast-cancer-20222026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-patient-characteristics-and-treatment-patterns-among-cholangiocarcinoma-patients-treated-with-fgfr-inhibitors2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-multi-agent-ai-system-integrating-real-world-data-and-competitive-intelligence-to-generate-automated-trial-eligibility-recommendations2026-07-07https://itsupport.concertai.com/testing-dynamic-2/data-stacking-of-rwd-from-two-emr-databases-in-the-united-states-using-tokenization2026-07-07https://itsupport.concertai.com/testing-dynamic-2/secondary-primary-malignancies-spms-in-adolescent-and-young-adults-ayas-with-multiple-myeloma-mm-an-asco-cancerlinq-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/effectiveness-outcomes-and-health-related-quality-of-life-impact-of-disease-progression-in-patients-with-advanced-nonsquamous-nsclc-treated-in-real-world-community2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-among-patients-with-unresected-stage-iii-non-small-cell-lung-cancer-nsclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/kras-testing-of-mcrc-patients-in-a-community-based-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a0882-subsequent-treatment-patterns-and-outcomes-among-patients-with-muscle-invasive-bladder-cancer-mibc-receiving-neoadjuvant-treatments-a-real-world-data-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/association-of-mrna-covid-19-vaccination-near-immune-checkpoint-inhibitor-initiation-with-outcomes-a-real-world-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/disease-free-survival-dfs-as-a-predictor-of-overall-survival-in-completely-reseacted-early-stage-non-small-cell-lung-cancer-nsclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/b057-pathway-level-molecular-evolution-and-composite-molecular-genomic-risk-following-lu-177-psma-617-in-metastatic-castration-resistant-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/challenges-in-analyzing-real-world-evidence-analysis-of-androgen-deprivation-therapy-use-for-prostate-cancer-in-the-reassure-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comparison-of-advanced-ovarian-cancer-patients-treated-with-or-without-bevacizumab-in-the-us-community-oncology-clinics2026-07-07https://itsupport.concertai.com/testing-dynamic-2/association-of-treatment-induced-peripheral-neuropathy-tipn-with-treatment-patterns-and-outcomes-in-patients-with-newly-diagnosed-multiple-myeloma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-and-provider-characteristics-associated-with-first-line-treatment-of-hr-plus-her2-metastatic-breast-cancer-patients-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-of-different-lines-and-sequences-of-treatment-in-braf-positive-advanced-melanoma-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/augmenting-external-control-arms-using-bayesian-borrowing-a-case-study-in-first-line-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/race-differences-in-patient-reported-symptoms-and-adherence-to-adjuvant-endocrine-therapy-among-women-with-early-stage-hormone-receptor-positive-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-effectiveness-outcomes-in-patients-with-relapsed-refractory-classical-hodgkins-lymphoma-that-received-autologous-and-or-allogenic-stem-cell2026-07-07https://itsupport.concertai.com/testing-dynamic-2/performance-status-classification-of-lung-cancer-patients-by-trained-machine-leaning2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-effectiveness-outcomes-and-healthcare-resource-utilization-of-patients-diagnosed-with-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/management-of-severe-immune-related-adverse-events-and-outcomes-in-patients-with-advanced-non-small-cell-lung-cancer-receiving-immune-checkpoint-inhibitors2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-of-patients-with-metastatic-colorectal-cancer-mcrc-treated-with-trifluridine-tipiracil-plus-bevacizumab-by-performance-status2026-07-07https://itsupport.concertai.com/testing-dynamic-2/leveraging-real-world-data-sources-for-clinical-oncology-research-a-review-of-studies-published-in-asco-publications2026-07-07https://itsupport.concertai.com/testing-dynamic-2/developing-a-pan-cancer-foundation-model-for-digital-patient-representation-and-clinical-prediction-across-real-world-oncology-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identifying-non-small-cell-lung-cancer-patients-from-a-cohort-of-heterogeneous-lung-cancer-patients-using-boosted-trees-on-electronic-health-records-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/machine-learning-imputation-of-metastatic-status-from-open-claims-in-melanoma-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/contemporary-real-world-patterns-of-precision-medicine-in-metastatic-nsclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-survey-of-the-impact-of-toxicities-with-folfox-plus-bevacizumab-bv-in-1st-line-metastatic-colorectal-cancer-mcrc-in-the-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/effect-of-covid-19-vaccination-status-on-adverse-events-and-outcomes-in-advanced-non-small-cell-lung-cancer-ansclc-patients-treated-with-immunotherapies2026-07-07https://itsupport.concertai.com/testing-dynamic-2/electronic-clinical-quality-measure-ecqm-concordance-and-quality-care-disparities-among-patients-with-breast-cancer-bc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/thrive-study-protocol-a-randomized-controlled-trial-evaluating-a-web-based-app-and-tailored-messages-to-improve-adherence-to-adjuvant-endocrine-therapy-among-women-with2026-07-07https://itsupport.concertai.com/testing-dynamic-2/efficacy-of-lurbinectedin-in-a-clinical-trial-versus-standard-of-care-in-a-real-world-comparator-arm-in-relapsed-refractory-small-cell-lung-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/disruptions-to-us-medical-oncology-care-during-the-covid-19-pandemic-cancerlinq-discovery-clqd-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/initial-treatment-and-changes-in-adjuvant-endocrine-therapy-for-early-stage-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pp01-46-real-world-rebiopsy-and-biomarker-retesting-rates-among-patients-with-non-small-cell-lung-cancer-across-patient-demographics-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/integrated-multi-setting-real-world-data-to-advance-bladder-cancer-evidence-generation2026-07-07https://itsupport.concertai.com/testing-dynamic-2/5339-7-prevalence-and-distinct-biological-programs-of-small-cell-lung-cancer-molecular-subtypes-revealed-by-real-world-clinico-genomics-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/national-perspectives-on-artificial-intelligence-use-in-cancer-care-confidence-adoption-and-barriers2026-07-07https://itsupport.concertai.com/testing-dynamic-2/enhancing-diversity-in-oncology-clinical-trials-findings-of-a-case-study-in-improving-black-patient-representation-in-a-multiple-myeloma-trial2026-07-07https://itsupport.concertai.com/testing-dynamic-2/an-adjusted-treatment-comparison-comparing-amivantamab-versus-real-world-clinical-practice-in-europe-and-the-united-states-for-patients-with-advanced-non-small-cell2026-07-07https://itsupport.concertai.com/testing-dynamic-2/assessing-the-real-world-cost-of-care-in-patients-with-metastatic-triple-negative-breast-cancer-mtnbc-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-side-effects-of-targeted-therapies-high-throughput-association-studies-leveraging-the-cancerlinq-discovery-lung-cancer-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/us-burden-of-illness-associated-with-adjuvant-therapy-for-stage-i-iii-melanoma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/194-immune-related-adverse-events-of-anti-pd-l-1-immunotherapy-with-and-without-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-a-real-world-evidence2026-07-07https://itsupport.concertai.com/testing-dynamic-2/p1-08-09-real-world-outcomes-comparing-3-monthly-with-monthly-goserelin-implant-in-premenopausal-women-with-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/cancer-registry-data-linkage-of-electronic-health-record-data-from-asco-s-cancerlinq-evaluation-of-advantages-limitations-and-lessons-learned2026-07-07https://itsupport.concertai.com/testing-dynamic-2/f3-shifting-treatment-patterns-in-chromophobe-renal-cell-carcinoma-a-u-s-real-world-data-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/anemia-related-costs-and-adverse-event-rates-in-cancer-patients-who-do-not-respond-to-erythropoietin-stimulating-agents2026-07-07https://itsupport.concertai.com/testing-dynamic-2/correlation-analysis-of-invasive-disease-free-survival-and-overall-survival-in-a-real-world-population-of-patients-with-hr-plus-her2-early-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/emulations-of-oncology-trials-using-real-world-data-a-systematic-literature-review2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-medical-resource-use-and-costs-associated-with-second-line-treatment-of-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pb2779-chart-review-study-on-dose-modifications-of-patients-with-myelodysplastic-syndrome-treated-with-hypomethylating-agents2026-07-07https://itsupport.concertai.com/testing-dynamic-2/validation-of-the-patient-care-monitor-version-2-0-a-review-of-system-assessment-instrument-for-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-cancer-care-monitor-psychometric-content-evaluation-and-pilot-testing-of-a-computer-administered-system-for-symptom-screening-and-quality-of-life-in-adult-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/outcomes-for-patients-with-chronic-lymphocytic-leukemia-previously-treated-with-a-covalent-btk-inhibitor-and-bcl2-inhibitor-in-the-united-states-a-real-world-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/electronic-health-record-ehr-based-machine-learning-ml-to-predict-disease-recurrence-after-surgical-resection-of-early-stage-non-small-cell-lung-cancer-ensclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/multiple-myeloma-in-adolescent-and-young-adults-an-asco-cancerlinq-and-seer-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/health-resource-utilization-and-costs-in-brca-positive-metastatic-breast-cancer-patients-treated-in-the-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/metastatic-colorectal-cancer-patients-treated-with-a-biosimilar-to-bevacizumab-in-real-world-clinical-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/evaluation-of-patients-with-multiple-egfr-genomic-tests-in-the-metastatic-nsclc-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-and-economic-impact-of-recurrence-in-early-stage-non-small-cell-lung-cancer-following-complete-resection2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-united-states-based-real-world-study-on-biomarker-testing-and-rebiopsy-rates-among-patients-with-non-small-cell-lung-cancer-across-lines-of-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-prospective-study-comparing-ai-based-clinical-trial-eligibility-screening-with-traditional-emr-based-screening2026-07-07https://itsupport.concertai.com/testing-dynamic-2/machine-learning-modeling-of-real-world-primary-resistance-and-hyperprogression-in-immune-checkpoint-inhibitor-ici-treated-advanced-non-small-cell-lung-cancer-ansclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-evidence-provides-clinical-insights-into-tissue-agnostic-therapeutic-approvals2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-in-metastatic-bladder-cancer-in-community-oncology-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/unfavorable-early-stage-hodgkin-lymphoma-assessment-of-patient-characteristics-in-a-real-world-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/predicting-risk-of-chemotherapy-induced-side-effects-in-patients-with-colon-cancer-with-single-nucleotide-polymorphism-snp-bayesian-networks-bns2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-in-metastatic-hr-plus-her2-her2-plus-and-triple-negative-breast-cancer-after-start-of-first-line-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/3358-real-world-evaluation-of-outcomes-in-relapsed-refractory-multiple-myeloma-patients-that-are-triple-class-exposed-after-receiving-2-or-more-prior-lines-of-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/development-of-cancerlinq-a-health-information-learning-platform-from-multiple-electronic-health-record-systems-to-support-improved-quality-of-care2026-07-07https://itsupport.concertai.com/testing-dynamic-2/overall-survival-throughout-treatment-course-among-patients-diagnosed-with-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/disease-free-and-overall-survival-outcomes-for-localized-rcc-patients-by-disease-stage2026-07-07https://itsupport.concertai.com/testing-dynamic-2/predictive-modeling-for-survival-outcomes-in-surgically-resected-pancreatic-ductal-adenocarcinoma-a-comprehensive-machine-learning-approach-using-real-world-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-in-patients-pts-with-metastatic-triple-negative-breast-cancer-mtnbc-treated-with-sacituzumab-govitecan-sg-in-2l-plus-in-the-united-states-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/integrating-real-world-histopathological-and-clinicogenomic-data-from-1799-lung-cancer-patients-by-applying-unsupervised-deep-learning2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-among-patients-with-metastatic-colorectal-cancer-treated-first-line-with-a-bevacizumab-biosimilar-bevacizumab-awwb2026-07-07https://itsupport.concertai.com/testing-dynamic-2/development-of-an-algorithm-using-natural-language-processing-to-identify-metastatic-breast-cancer-patients-from-clinical-notes2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-among-patients-with-metastatic-melanoma-treated-in-the-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-impact-of-extended-endocrine-therapy-on-symptom-burden-and-health-related-quality-of-life-in-patients-with-early-stage-breast-cancer-esbc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/efficient-site-selection-for-clinical-trials-using-simulated-annealing2026-07-07https://itsupport.concertai.com/testing-dynamic-2/2477p-real-world-prostate-specific-antigen-psa-response-with-darolutamide-or-abiraterone-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-triplet-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/biomarker-defined-outcomes-in-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-receiving-first-line-1l-immune-checkpoint-inhibitor-based-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-following-ibrutinib-dose-reduction-in-patients-with-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/using-an-epro-tool-to-help-meet-quality-metrics-in-a-community-oncology-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/5189-real-world-use-patterns-and-clinical-outcomes-for-myelodysplastic-syndrome-patients-initiating-oral-decitabine-and-cedazuridine-or-intravenous-subcutaneous2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-tx-patterns-in-patients-pts-with-hr-plus-her2-metastatic-breast-cancer-mbc-treated-with-chemotherapy-ct-in-the-united-states-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-impact-of-treatment-induced-peripheral-neuropathy-of-patient-reported-outcomes-in-patients-with-multiple-myeloma-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-characteristics-and-costs-in-advanced-head-and-neck-cancer-retrospective-analysis-of-a-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-progression-free-survival-and-treatment-patterns-for-t-11-14-positive-patients-with-multiple-myeloma-with-at-least-2-prior-lines-of-treatment2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-survival-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc-who-previously-progressed-from-metastatic-hormone-sensitive2026-07-07https://itsupport.concertai.com/testing-dynamic-2/electronic-health-record-ehr-and-genomics-based-machine-learning-ml-to-predict-therapeutic-effectiveness-among-patients-with-hormone-receptor-positive-hr-plus-her22026-07-07https://itsupport.concertai.com/testing-dynamic-2/patients-with-advanced-non-small-cell-lung-cancer-harboring-met-alterations-a-descriptive-cohort-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-use-of-accelerated-approval-oncology-drugs-subsequently-withdrawn-in-the-united-states-20252026-07-07https://itsupport.concertai.com/testing-dynamic-2/effect-of-pegfilgrastim-on-body-injector-obi-on-cancer-care-a-real-world-health-system-and-interrupted-time-series-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/streamline-retrospective-cohort-study-of-flt3-mutated-acute-myeloid-leukemia-aml-real-world-treatment-patterns-and-clinical-outcomes-after-first-relapse-or-refractory-r2026-07-07https://itsupport.concertai.com/testing-dynamic-2/demographics-and-clinical-characteristics-of-metastatic-colorectal-cancer-patients-treated-with-bevacizumab-awwb-in-real-world-oncology-clinics2026-07-07https://itsupport.concertai.com/testing-dynamic-2/behavior-of-test-specificity-under-an-imperfect-gold-standard-findings-from-a-simulation-study-and-analysis-of-real-world-oncology-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-evidence-comparison-of-first-line-1l-immune-oncology-io-tyrosine-kinase-inhibitor-tki-vs-io-io-combination-therapy-in-renal-cell-carcinoma-rcc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/po1-17-07-invasive-disease-free-survival-as-a-surrogate-for-overall-survival-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor-receptor-22026-07-07https://itsupport.concertai.com/testing-dynamic-2/rwd23-addition-of-open-administrative-claims-significantly-improves-capture-of-mortality-in-electronic-health-record-ehr-focused-real-world-data-rwd2026-07-07https://itsupport.concertai.com/testing-dynamic-2/unmet-need-in-heavily-pre-treated-patients-with-hr-plus-her2-metastatic-breast-cancer-mbc-in-the-us-a-concertai-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/racial-and-ethnic-representation-in-large-b-cell-lymphoma-trials-and-real-world-databases2026-07-07https://itsupport.concertai.com/testing-dynamic-2/healthcare-resource-utilization-and-cost-among-patients-treated-for-early-stage-triple-negative-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/5143-impact-of-real-world-treatment-sequencing-patterns-on-time-to-next-treatment-among-patients-with-chronic-lymphocytic-leukemia-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/vital-status-ascertainment-in-cancerlinq-discovery-clqd-improvement-in-mortality-capture-with-a-supplemental-data-source2026-07-07https://itsupport.concertai.com/testing-dynamic-2/impact-of-broadening-clinical-trial-eligibility-criteria-for-advanced-non-small-cell-lung-cancer-patients-real-world-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-outcomes-in-patients-with-metastatic-neuroendocrine-tumors-a-retrospective-analysis-of-a-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/augmenting-synthetic-control-arms-using-bayesian-borrowing-a-case-study-in-first-line-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/symptom-burden-and-quality-of-life-among-patients-receiving-second-line-treatment-of-metastatic-colorectal-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/association-between-severe-adverse-event-management-and-overall-survival-in-patients-treated-with-immune-checkpoint-inhibitor-with-advanced-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/retrospective-analysis-of-real-world-management-of-egfr-mutated-advanced-nsclc-after-first-line-egfr-tki-treatment-us-treatment-patterns-attrition-and-survival-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/use-of-the-patient-care-monitor-to-screen-for-depression-in-adult-cancer-patients-interviewed-with-the-structured-clinical-interview-for-dsm-iv2026-07-07https://itsupport.concertai.com/testing-dynamic-2/racial-differences-in-patient-reported-symptoms-and-adherence-to-adjuvant-endocrine-therapy-among-women-with-early-stage-hormone-receptor-positive-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/post-metastasis-survival-in-high-risk-localised-and-locally-advanced-prostate-cancer-patients-undergoing-primary-treatment-in-the-united-states-a-retrospective-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-clinical-outcomes-health-resource-utilization-and-cost-in-patients-with-brca-mutated-metastatic-breast-cancer-treated-in-community-oncology-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/predicting-cardiac-adverse-events-in-patients-receiving-immune-checkpoint-inhibitors-a-machine-learning-approach2026-07-07https://itsupport.concertai.com/testing-dynamic-2/effect-of-brain-metastasis-on-patient-reported-outcomes-in-advanced-nsclc-treated-in-real-world-community-oncology-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/capturing-patient-advance-directives-status-in-a-community-oncology-practice-using-an-electronic-patient-reported-outcomes-epro-system2026-07-07https://itsupport.concertai.com/testing-dynamic-2/performance-of-time-to-discontinuation-and-time-to-next-treatment-as-proxy-measures-of-progression-free-survival-overall-and-by-treatment-group2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-use-patterns-effectiveness-and-tolerability-of-sacituzumab-govitecan-for-second-line-and-later-line-treatment-of-metastatic-triple-negative-breast-cancer-in2026-07-07https://itsupport.concertai.com/testing-dynamic-2/digital-trial-solutions-escreening-software-to-rank-patients-by-their-predicted-clinical-trial-eligibility-using-real-world-data-and-machine-learning2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-outcomes-with-alpelisib-alp-plus-fulvestrant-ful-after-prior-treatment-tx-with-ful-in-patients-pts-with-advanced-breast-cancer-abc-a-real-world-rw-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-of-metastatic-renal-cell-carcinoma-mrcc-in-community-and-academic-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/evaluation-of-cost-effectiveness-of-adjuvant-osimertinib-in-patients-with-resected-egfr-mutation-positive-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-in-patients-pts-with-hr-plus-her2-metastatic-breast-cancer-mbc-treated-with-chemotherapy-ct-in-the-united-states-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-pitfalls-of-analyzing-real-world-data-a-cautionary-note-and-path-forward2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-among-metastatic-colorectal-cancer-mcrc-patients-with-liver-metastases-who-received-trifluridine-tipiracil-ftd-tpi-or-ftd-tpi-plus2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-resect-study-factors-associated-with-overall-survival-os-and-relapse-free-survival-rfs-among-patients-with-stages-i-iii-resected-nsclc-without-known-egfr-mutations2026-07-07https://itsupport.concertai.com/testing-dynamic-2/racial-disparities-in-clinical-trial-enrollment-among-patients-diagnosed-with-prostate-cancer-a-population-based-cohort-of-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/use-of-immunosuppressive-drugs-and-the-effectiveness-of-immune-checkpoint-inhibitor-therapy-among-patients-with-advanced-metastatic-non-small-cell-lung-cancer-in-the2026-07-07https://itsupport.concertai.com/testing-dynamic-2/enhancement-in-line-of-therapy-lot-derivation-from-real-world-data-rwd-from-electronic-health-records-ehr-via-integration-of-medical-claims-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-clinical-outcomes-with-palbociclib-combination-therapy-received-in-us-community-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identification-of-transgender-people-with-cancer-in-electronic-health-records-recommendations-based-on-cancerlinq-observations2026-07-07https://itsupport.concertai.com/testing-dynamic-2/dynamic-machine-learning-model-to-forecast-patient-availability-for-clinical-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/site-of-metastasis-som-and-its-impact-on-clinical-outcomes-in-8-cancer-cohorts2026-07-07https://itsupport.concertai.com/testing-dynamic-2/803-representativeness-of-race-ethnicity-and-social-determinants-of-health-in-patients-with-advanced-non-small-cell-lung-cancer-via-linkage-of-real-world-electronic2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-in-patients-receiving-neoadjuvant-chemotherapy-for-early-stage-triple-negative-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/locoregional-recurrence-in-patients-with-early-stage-triple-negative-breast-cancer-receiving-neoadjuvant-systemic-therapy-patient-characteristics-and-clinical-outcomes2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-real-world-study-on-biomarker-retesting-among-patients-with-non-small-cell-lung-cancer-and-disparity-in-outcomes2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-testing-patterns-and-clinical-outcomes-of-first-line-1l-therapy-for-metastatic-gastric-cancer-gastroesophageal-junction-cancer-or2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-outcomes-of-cabazitaxel-or-subsequent-androgen-receptor-pathway-inhibitor-arpi-in-post-docetaxel-arpi-metastatic-castration-resistant-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/hsd64-real-world-adjuvant-nivolumab-utilization-in-surgically-treated-muscle-invasive-bladder-cancer-patients-within-u-s-community-oncology-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-of-hepatocellular-carcinoma-hcc-patients-pts-in-the-cancerlinq-research-database-clq2026-07-07https://itsupport.concertai.com/testing-dynamic-2/573p-luminate-103-real-world-treatment-patterns-and-outcomes-of-patients-pts-with-epidermal-growth-factor-receptor-mutant-egfr-mu-non-squamous-nsq-locally-advanced2026-07-07https://itsupport.concertai.com/testing-dynamic-2/evaluating-clinical-trial-inclusion-exclusion-criteria-from-claims-using-generative-artificial-intelligence2026-07-07https://itsupport.concertai.com/testing-dynamic-2/prognostic-score-models-for-acquired-resistance-to-frontline-anti-programmed-cell-death-protein-1-programmed-death-ligand-1-therapy-in-metastatic-non-small-cell-lung2026-07-07https://itsupport.concertai.com/testing-dynamic-2/racial-disparities-in-performance-status-among-cancer-patients-at-a-community-oncology-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/natural-history-and-real-world-treatment-outcomes-for-non-small-cell-lung-cancer-patients-with-egfr-exon-20-insertion-mutation-an-iaslc-asco-cancerlinq-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/symptom-burden-declines-when-breast-cancer-patients-treated-with-adjuvant-trastuzumab-combination-chemotherapy-regimens-enter-trastuzumab-monotherapy-follow-up2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-outcomes-of-patients-with-metastatic-colorectal-cancer-treated-with-trifluridine-tipiracil-plus-bevacizumab-by-performance-status2026-07-07https://itsupport.concertai.com/testing-dynamic-2/co125-adjusted-comparison-of-amivantamab-in-combination-with-carboplatin-plus-pemetrexed-from-the-papillon-study-versus-us-real-world-frontline-treatments-in-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/post-metastasis-survival-of-patients-with-high-risk-localized-and-locally-advanced-prostate-cancer-undergoing-primary-treatment-in-the-united-states-a-retrospective-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-evidence-on-use-of-tumor-mutation-burden-in-a-pan-tumor-population2026-07-07https://itsupport.concertai.com/testing-dynamic-2/characteristics-of-real-world-natalee-and-monarche-eligible-populations-with-hr-plus-her2-early-breast-cancer-a-united-states-electronic-health-records-database-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-and-health-economic-burden-of-attempted-primary-cancer-site-identification-in-patients-presenting-with-cancer-of-unknown-primary2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-health-resource-utilization-among-patients-diagnosed-with-early-stage-resected-non-small-cell-lung-cancer-nsclc-at-community-oncology2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identification-of-transgender-people-with-cancer-in-electronic-health-records-ehr-recommendations-based-on-cancerlinq-observations2026-07-07https://itsupport.concertai.com/testing-dynamic-2/impact-of-trial-site-selection-on-minority-patient-recruitment-in-prostate-cancer-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-survival-in-people-with-metastatic-castration-resistant-prostate-cancer-following-metastatic-hormone-sensitive-disease-between-20202026-07-07https://itsupport.concertai.com/testing-dynamic-2/74-real-world-study-characterizing-patient-characteristics-treatments-and-unmet-need-in-io-ineligible-patients-with-metastatic-triple-negative-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/quality-of-life-analysis-of-patients-treated-with-cetuximab-or-cisplatin-for-locoregionally-advanced-squamous-cell-carcinoma-of-head-and-neck-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/genomic-landscape-of-patients-with-non-small-cell-lung-cancer-nsclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/characteristics-of-patients-treated-with-fulvestrant-as-first-hormonal-therapy-for-metastatic-breast-cancer-in-a-real-world-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/harmonizing-logical-observation-identifiers-names-and-codes-loinc-codes-and-units-in-real-world-oncology-data-method-development-and-evaluation2026-07-07https://itsupport.concertai.com/testing-dynamic-2/recurrence-and-its-association-with-overall-survival-os-in-muscle-invasive-bladder-cancer-mibc-patients-undergoing-radical-cystectomy-rc-a-real-world-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-study-of-use-patterns-and-clinical-outcomes-for-patients-with-myelodysplastic-syndrome-initiating-oral-decitabine-and-cedazuridine-or-intravenous2026-07-07https://itsupport.concertai.com/testing-dynamic-2/retrospective-study-of-the-effect-of-disease-progression-on-patient-reported-outcomes-in-her-2-negative-metastatic-breast-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/occurrence-of-brain-metastasis-and-treatment-patterns-among-patients-with-her2-positive-metastatic-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-management-and-outcomes-for-newly-diagnosed-aml-patients-initiating-venetoclax-and-hypomethylating-agents-in-us-community-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-among-patients-with-metastatic-melanoma-treated-in-community-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/improving-real-world-mortality-data-quality-in-oncology-research-augmenting-electronic-medical-records-with-obituary-social-security-death-index-and-commercial-claims2026-07-07https://itsupport.concertai.com/testing-dynamic-2/mds-567-real-world-analysis-of-a-large-electronic-medical-record-database-of-patients-with-higher-risk-myelodysplastic-neoplasms-hr-mds-treatment-profiles-clinical2026-07-07https://itsupport.concertai.com/testing-dynamic-2/evaluation-of-treatment-strategies-for-patients-with-stage-iiia-non-small-cell-lung-cancer-in-the-immunotherapy-era2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pb2488-chart-review-study-on-the-real-world-cytopenia-management-of-patients-with-acute-myeloid-leukemia-treated-with-venetoclax-and-hypomethylating-agents2026-07-07https://itsupport.concertai.com/testing-dynamic-2/assessing-direct-costs-of-treating-metastatic-triple-negative-breast-cancer-in-the-usa2026-07-07https://itsupport.concertai.com/testing-dynamic-2/873ep-real-world-characteristics-and-outcomes-of-patients-with-third-line-or-later-metastatic-colorectal-cancer-magnetic-101-study-results2026-07-07https://itsupport.concertai.com/testing-dynamic-2/1482-21-a-deep-learning-based-multimodal-integration-framework-for-clinical-outcome-prediction2026-07-07https://itsupport.concertai.com/testing-dynamic-2/challenges-to-using-big-data-in-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/early-treatment-discontinuation-and-switching-in-1st-line-metastatic-breast-cancer-impact-of-symptom-burden-in-a-real-world-sample2026-07-07https://itsupport.concertai.com/testing-dynamic-2/diagnosed-with-advanced-prostate-cancer-a-population-based-cohort-from-national-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-of-metastatic-renal-cell-carcinoma-in-a-joint-community-academic-cohort-progression-free-survival-over-three-lines-of-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-clinical-outcomes-with-palbociclib-based-therapy-received-in-us-community-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/development-of-natural-language-processing-nlp-models-for-extracting-key-features-from-unstructured-notes-to-create-real-world-data-rwd-assets-for-clinical-research-at2026-07-07https://itsupport.concertai.com/testing-dynamic-2/abstract-a131-clinical-characteristics-and-outcomes-of-black-patients-with-multiple-myeloma-compared-with-other-races2026-07-07https://itsupport.concertai.com/testing-dynamic-2/harness-the-power-of-real-world-data-for-oncology-target-and-biomarker-research-a-case-study-by-applying-clinic-genomics-data-for-2-659-lung-cancer-patients-and-beyond2026-07-07https://itsupport.concertai.com/testing-dynamic-2/streamline-study-of-relapse-or-refractory-r-r-flt3-mutated-acute-myeloid-leukemia-aml-using-electronic-medical-records-emr-first-analysis-from-a-multicenter2026-07-07https://itsupport.concertai.com/testing-dynamic-2/case-studies-for-overcoming-challenges-in-using-big-data-in-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/associations-between-biomarker-testing-and-characteristics-of-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc-an-analysis-of-cancerlinq-discovery-clqd-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-patient-characteristics-and-treatment-patterns-in-us-patients-with-advanced-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/p3-03-12-social-determinants-of-health-sdoh-and-z-code-utilization-among-patients-with-breast-cancer-bc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/aragon-ching-jb-pierattini-c-karovic-s-dvergsten-e2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-associated-with-sequential-and-non-sequential-use-of-cdk4-and-6i-for-hr-plus-her2-mbc-in-the-real-world2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-healthcare-resource-utilization-in-patients-with-waldenstrom-macroglobulinemia-initiating-first-line-treatment-with-ibrutinib-or2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-retrospective-analysis-of-treatment-patterns-overall-survival-and-real-world-disease-free-survival-in-early-stage-non-small-cell-lung-cancer-following-complete2026-07-07https://itsupport.concertai.com/testing-dynamic-2/cohort-optimizer-a-software-solution-that-uses-real-world-data-and-ai-to-optimize-criteria-of-oncology-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-in-metastatic-gastric-cancer-in-the-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/impact-of-broadening-trial-eligibility-criteria-for-patients-with-advanced-non-small-cell-lung-cancer-real-world-analysis-of-select-asco-friends-recommendations2026-07-07https://itsupport.concertai.com/testing-dynamic-2/5100-machine-learning-approach-to-understand-real-world-treatment-in-patients-with-higher-risk-myelodysplastic-syndromes2026-07-07https://itsupport.concertai.com/testing-dynamic-2/community-oncology-treatment-patterns-and-clinical-effectiveness-in-metastatic-castration-resistant-prostate-cancer-mcrpc-patients-who-progressed-after-docetaxel2026-07-07https://itsupport.concertai.com/testing-dynamic-2/1303p-metpro-evaluating-prognostic-value-of-c-met-protein-overexpression-and-concurrent-biomarker-presence2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-outcomes-among-metastatic-castration-resistant-prostate-cancer-patients-treated-with-androgen-receptor-pathway-inhibitor-and-docetaxel2026-07-07https://itsupport.concertai.com/testing-dynamic-2/time-spent-on-rituximab-infusion-and-its-impact-on-patient-and-caregiver-burden2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-survival-benefit-of-anti-her2-treatment-in-the-management-of-small-t1mic-t1a-t1b-t1c-node-negative-her2-plus-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/sunniforecast-trial-design-supported-by-real-world-data-in-papillary-renal-cell-carcinoma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-clinical-effectiveness-in-metastatic-castrate-resistant-prostate-cancer-after-first-line-docetaxel2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-outcomes-in-pd-l1-positive-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/machine-learning-ml-model-for-prediction-of-pneumonitis-using-real-world-data-rwd-on-immune-checkpoint-inhibitor-ici-treated-advanced-non-small-cell-lung-cancer-ansclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/development-of-a-breast-cancer-specific-prognostic-tool-using-cancerlinq-discovery2026-07-07https://itsupport.concertai.com/testing-dynamic-2/quantitating-and-assessing-interoperability-between-electronic-health-records2026-07-07https://itsupport.concertai.com/testing-dynamic-2/budget-impact-of-pirtobrutinib-for-patients-with-mantle-cell-lymphoma-mcl-or-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-cll-sll-in-the-united-states-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-qualitative-exploration-of-race-based-differences-in-social-support-needs-of-diverse-women-with-breast-cancer-on-adjuvant-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/differences-by-race-in-patient-reported-symptoms-during-chemotherapy-among-women-with-early-stage-hormone-receptor-positive-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/analysis-of-asco-clinical-guidelines-authorship-and-institutional-representation-using-hemonc-org2026-07-07https://itsupport.concertai.com/testing-dynamic-2/242-a-combined-machine-learning-and-natural-language-processing-approach-to-determine-metastatic-date-through-integrated-temporal-modeling2026-07-07https://itsupport.concertai.com/testing-dynamic-2/assessment-of-differences-in-demographic-characteristics-and-clinical-diagnoses-among-black-and-white-oncology-patients-with-covid2026-07-07https://itsupport.concertai.com/testing-dynamic-2/effectiveness-outcomes-in-patients-with-recurrent-or-refractory-head-and-neck-cancers-retrospective-analysis-of-data-from-a-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/picturing-progression-a-new-role-of-whole-slide-imaging-in-comprehensive-clinical-genomic-datasets2026-07-07https://itsupport.concertai.com/testing-dynamic-2/maximizing-the-utility-of-real-world-evidence-integration-of-structured-electronic-medical-record-emr-data-unstructured-emr-data-and-billing-data-for-economics-and2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-intensification-in-metastatic-hormone-sensitive-prostate-cancer-an-analysis-of-real-world-practice-patterns-from-the-cancerlinq-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comparative-effectiveness-of-abiraterone-and-enzalutamide-in-the-first-line-treatment-of-metastatic-castration-resistant-prostate-cancer-mcrpc-a-retrospective-cohort2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-outcomes-of-apalutamide-as-a-starting-treatment-impact-in-real-world-patients-with-metastatic-hormone-sensitive-prostate-cancer-oasis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/using-text-mining-of-electronic-medical-records-to-identify-kras-testing-status-in-mcrc-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-among-patients-with-metastatic-colorectal-cancer-treated-first-line-with-bevacizumab-awwb2026-07-07https://itsupport.concertai.com/testing-dynamic-2/health-care-cost-in-patients-with-advanced-non-small-cell-lung-cancer-and-disease-progression-on-targeted-treatment-in-a-real-world-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/epidemiology-of-met-gene-mrna-expression-in-metastatic-colorectal-cancer-analyses-of-a-real-world-clinicogenomic-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/adverse-events-aes-by-age-data-from-a-real-world-multicenter-registry-of-patients-treated-for-metastatic-renal-cell-carcinoma-mrcc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comparing-prospectively-assigned-trial-and-real-world-lung-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/androgen-receptor-pathway-inhibitors-triplet-therapy-araat-real-world-outcomes-in-metastatic-hormone-sensitive-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/psychosocial-impact-of-cancer-related-symptoms-among-patients-with-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/trends-in-immunotherapy-use-in-patients-with-advanced-non-small-cell-lung-cancer-ansclc-patients-analysis-of-real-world-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/impact-of-curated-data-on-electronic-quality-measure-capture-rates-within-cancerlinq2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a0394-molecular-evolution-and-resistance-mechanisms-after-lu-177-psma-617-in-metastatic-castration-resistant-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/mp31-17-variation-in-genomic-testing-amongst-localized-prostate-cancer-patients-undergoing-radical-prostatectomy-or-radiation-therapy-results-from-a-population-based2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-outcomes-in-patients-with-hr-plus-her2-metastatic-breast-cancer-treated-with-chemotherapy-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/p32-oncology-trial-emulation-using-real-world-electronic-health-record-data-results-of-the-coalition-to-advance-real-world-evidence-through-randomized-controlled-trial2026-07-07https://itsupport.concertai.com/testing-dynamic-2/folate-receptor-alpha-fr-alpha-folr1-expression-and-persistence-in-ovarian-cancer-in-clinical-trial-samples-and-real-world-patient-cohort2026-07-07https://itsupport.concertai.com/testing-dynamic-2/natural-language-processing-optimized-case-selection-for-real-world-evidence-studies2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-in-the-real-world-a-national-analysis-of-patients-treated-for-early-stage-breast-cancer-20212026-07-07https://itsupport.concertai.com/testing-dynamic-2/association-of-treatment-induced-peripheral-neuropathy-with-treatment-patterns-and-outcomes-in-patients-with-newly-diagnosed-multiple-myeloma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/electronic-health-records-ehr-based-machine-learning-ml-approach-to-predict-risk-of-progression-to-metastatic-melanoma-after-initial-diagnosis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/machine-learning-imputation-of-eastern-cooperative-oncology-group-performance-status-ecog-ps-scores-from-data-in-cancerlinq-discovery2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-effectiveness-outcomes-in-patients-diagnosed-with-metastatic-triple-negative-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/health-data-sharing-perspectives-of-patients-receiving-care-in-cancerlinq-participating-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/development-of-an-artificial-intelligence-model-to-dynamically-predict-metastatic-recurrence-of-early-stage-breast-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-real-world-study-of-us-patients-with-metastatic-ovarian-fallopian-tube-and-peritoneal-cancer-mofpc-using-integrated-electronic-health-records-ehr-and-claims-datasets2026-07-07https://itsupport.concertai.com/testing-dynamic-2/use-of-real-world-data-to-describe-adverse-events-for-the-treatment-of-metastatic-renal-cell-carcinoma-in-routine-clinical-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/using-artificial-intelligence-to-improve-capture-of-metastatic-breast-cancer-bc-status-in-electronic-health-records-ehr2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-clinical-outcomes-post-standard-of-care-soc-among-patients-pts-with-metastatic-non-small-cell-lung-cancer-mnsclc-with-and-without2026-07-07https://itsupport.concertai.com/testing-dynamic-2/improving-cancer-data-interoperability-the-promise-of-the-minimal-common-oncology-data-elements-mcode-initiative2026-07-07https://itsupport.concertai.com/testing-dynamic-2/symptom-burden-and-quality-of-life-in-patients-with-follicular-lymphoma-undergoing-maintenance-treatment-with-rituximab-compared-with-observation2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-among-patients-with-unresected-stage-iii-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/274-epidemiology-of-met-gene-mrna-expression-in-metastatic-colorectal-cancer-analyses-of-a-real-world-clinicogenomic-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-among-patients-diagnosed-with-metastatic-castration-sensitive-prostate-cancer-mcspc-in-community-oncology-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-clinical-outcomes-among-patients-with-relapsed-refractory-classical-hodgkin-s-lymphoma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/1632p-predicting-real-world-overall-survival-in-advanced-melanoma-using-machine-learning2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-value-of-integrating-urology-and-oncology-real-world-data-for-understanding-prostate-cancer-management2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-in-metastatic-neuroendocrine-tumors-results-from-a-retrospective-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/p1-11-59-effect-of-ifng-expression-levels-on-real-world-survival-outcomes-in-patients-with-metastatic-non-small-cell-lung-cancer-receiving-immunotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/evaluation-of-real-world-tumor-response-derived-from-electronic-health-record-data-sources-a-feasibility-analysis-in-mnsclc-patients-treated-with-chemotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/1361-quantification-of-information-gained-by-linking-claims-data-to-an-ehr-cohort-of-us-metastatic-breast-cancer-mbc-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-effectiveness-outcomes-by-race-in-patients-with-metastatic-triple-negative-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/prevalence-of-insomnia-and-associated-symptoms-in-patients-with-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/symptom-burden-for-patients-with-metastatic-colorectal-cancer-treated-with-first-line-folfox-or-folfiri-with-and-without-bevacizumab-in-the-community-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/4437-real-world-treatment-patterns-in-patients-with-mycosis-fungoides-or-sezary-syndrome-treated-with-mogamulizumab-in-the-united-states-a-retrospective-database-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-effectiveness-of-egfr-tki-first-line-treatment-of-advanced-egfr-mutation-positive-non-small-cell-lung-cancer-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/seeking-american-society-of-clinical-oncology-qualityoncology-practice-initiative-asco-qopi-certification-in-anorthern-new-england-rural-health-system-and-cancer-care2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-outcomes-among-patients-with-unresected-stage-iii-non-small-cell-lung-cancer-nsclc-in-a-real-world-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/retrospective-chart-review-of-severe-infusion-reactions-with-rituximab-cetuximab-and-bevacizumab-in-community-oncology-practices-assessment-of-clinical-consequences2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-frontline-treatments-in-patients-with-advanced-non-small-cell-lung-cancer-harboring-epidermal-growth-factor-receptor-exon-20-insertions-and-adjusted2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comparing-traditional-nlp-methods-and-llm-based-extraction-for-identifying-biomarkers-in-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pd23-03-clinical-and-molecular-predictors-of-response-to-lu-177-psma-617-in-metastatic-castration-resistant-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-effectiveness-of-frontline-treatments-among-patients-with-chronic-lymphocytic-leukemia-results-from-concertai2026-07-07https://itsupport.concertai.com/testing-dynamic-2/overall-survival-in-egfr-mutant-advanced-nsclc-treated-with-first-line-osimertinib-a-cohort-study-integrating-clinical-and-biomarker-data-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/outcomes-for-patients-with-mantle-cell-lymphoma-post-covalent-btk-inhibitor-therapy-in-the-united-states-and-japan-a-study-of-two-real-world-databases-20212026-07-07https://itsupport.concertai.com/testing-dynamic-2/natural-history-and-real-world-treatment-outcomes-for-nsclc-patients-with-egfr-exon-20-insertion-mutation-an-iaslc-asco-cancerlinq-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/willingness-to-pay-for-preventing-chemotherapy-induced-nausea-and-vomiting-among-patients-with-breast-lung-or-colorectal-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/practice-patterns-of-community-based-adjuvant-hormonal-therapy-aht-in-early-stage-breast-cancer-esbc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/tumor-mutational-burden-tmb-level-and-clinical-outcomes-in-a-real-world-pan-tumor-population2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-reported-outcomes-in-metastatic-renal-cell-carcinoma-patients-receiving-pazopanib-in-a-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-prevalence-of-autoimmune-disease-ad-among-patients-pts-receiving-immune-checkpoint-inhibitors-ici-in-ascos-cancerlinq-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-rw-use-patterns-effectiveness-and-tolerability-of-sacituzumab-govitecan-sg-for-second-line-2l-and-later-treatment-of-metastatic-triple-negative-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/challenges-and-opportunities-to-developing-a-frailty-index-using-electronic-health-record-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/utilizing-data-visualization-to-identify-survival-and-treatment-differences-between-women-with-de-novo-and-recurrent-metastatic-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-clinical-characteristics-of-patients-with-advanced-basal-cell-carcinoma-abcc-in-the-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-among-advanced-non-small-cell-lung-cancer-patients-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-multi-agent-system-for-automated-identification-of-competitive-clinical-trials-in-colorectal-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/streamline-retrospective-cohort-study-of-fms-like-tyrosine-kinase-3-mutated-acute-myeloid-leukemia-real-world-treatment-patterns-and-clinical-outcomes-of-patients-in2026-07-07https://itsupport.concertai.com/testing-dynamic-2/hta91-correlation-of-intermediate-clinical-endpoints-ices-for-overall-survival-os-in-localized-or-locally-advanced-prostate-cancer-lpc-lapc-analysis-of-individual-real2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-effectiveness-of-fulvestrant-monotherapy-as-first-endocrine-treatment-in-patients-with-metastatic-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-in-stage-iv-bladder-cancer-in-a-community-oncology-setting-2008-20152026-07-07https://itsupport.concertai.com/testing-dynamic-2/prognosis-and-conditional-survival-among-women-with-newly-diagnosed-ovarian-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-of-patients-with-advanced-non-small-cell-lung-cancer-ansclc-and-autoimmune-disease-ad-receiving-immune-checkpoint-inhibitors-icis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/egfr-mutation-testing-treatment-and-survival-in-stage-i-iii-non-small-cell-lung-cancer-cancerlinq-discovery-database-retrospective-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-retrospective-study-of-quality-of-life-in-a-community-sample-of-patients-with-early-stage-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-characteristics-and-real-world-treatment-patterns-in-patients-with-early-stage-triple-negative-breast-cancer-receiving-neoadjuvant-chemotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-characteristics-in-the-second-and-third-line-therapy-setting-for-real-world-small-cell-lung-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-in-patients-with-kras-wild-type-metastatic-colorectal-cancer-treated-in-first-line-with-bevacizumab-or-cetuximab-containing-regimens2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pretreatment-costs-of-care-and-time-to-initial-treatment-for-patients-with-cancer-of-unknown-primary2026-07-07https://itsupport.concertai.com/testing-dynamic-2/artificial-intelligence-enabled-analysis-of-unstructured-ehr-data-for-identification-of-actionable-her2-low-breast-cancer-phenotypes2026-07-07https://itsupport.concertai.com/testing-dynamic-2/practice-patterns-and-outcomes-of-conventional-versus-split-dose-cisplatin-in-neoadjuvant-ddmvac-in-bladder-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/healthcare-costs-in-patients-with-advanced-non-small-cell-lung-cancer-and-disease-progression-during-targeted-therapy-a-real-world-observational-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/lurbinectedin-vs-an-external-control-arm-in-patients-with-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/390p-using-ai-methodology-to-stack-and-harmonize-two-u-s-emr-databases2026-07-07https://itsupport.concertai.com/testing-dynamic-2/systemic-anticancer-therapy-in-patients-with-de-novo-metastatic-pancreatic-adenocarcinoma-a-real-world-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/performance-of-time-to-discontinuation-and-time-to-next-treatment-as-proxy-measures-compared-with-direct-observation-of-progression-free-survival2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-patient-care-monitor-neutropenia-index-development-reliability-and-validity-of-a-measure-for-chemotherapy-induced-neutropenia2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-among-her2-positive-metastatic-breast-cancer-patients-treated-with-trastuzumab-deruxtecan-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-baseline-characteristics-of-a-prospective-cohort-of-patients-with-advanced-nsclc-treated-in-real-world-community-oncology-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/1433-pediatric-cancer-in-the-united-states-a-comparison-of-two-data-sources2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-recurrence-and-overall-survival-of-patients-with-muscle-invasive-bladder-cancer-undergoing-radical-cystectomy-in-u-s-oncology-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-in-patients-with-kras-wild-type-metastatic-colorectal-cancer-wtmcrc-treated-in-first-line-with-bevacizumab-b-or-cetuximab-c-containing2026-07-07https://itsupport.concertai.com/testing-dynamic-2/predicting-real-world-overall-survival-for-post-operative-pancreatic-ductal-adenocarcinoma-an-asco-cancerlinq-discovery-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/validation-of-the-cancer-care-monitor-items-for-physical-symptoms-and-treatment-side-effects-using-expert-oncology-nurse-evaluation2026-07-07https://itsupport.concertai.com/testing-dynamic-2/proportional-randomization-method-to-identify-index-line-of-therapy-in-externally-controlled-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/early-treatment-discontinuation-and-switching-in-first-line-metastatic-breast-cancer-the-role-of-patient-reported-symptom-burden2026-07-07https://itsupport.concertai.com/testing-dynamic-2/progression-free-survival-overall-survival-and-tumor-response-for-patients-diagnosed-with-small-cell-lung-cancer-who-received-first-line-systemic-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/ep-11a-08-real-world-comparative-effectiveness-in-advanced-nsclc-and-high-pd-l1-with-1l-immune-checkpoint-inhibitors-plus-minus-chemotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-patterns-on-tumor-mutation-burden-testing-in-a-pan-tumor-population2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pitfalls-with-analyses-of-real-world-data-a-look-at-ascos-cancerlinq-discovery-multiple-myeloma-dataset2026-07-07https://itsupport.concertai.com/testing-dynamic-2/artificial-intelligence-methods-to-predict-chemotherapy-induced-neutropenia-in-breast-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/4522-real-world-monotherapy-and-combination-usage-of-mogamulizumab-among-patients-with-mycosis-fungoides-or-sezary-syndrome-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/progression-free-survival-in-patients-receiving-chemotherapy-alone-c-or-chemotherapy-with-bevacizumab-cb-for-first-line-treatment-of-kras-mutant-metastatic-colorectal2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-outcomes-in-patients-pts-with-advanced-metastatic-nonsmall-cell-lung-cancer-nsclc-harboring-met-amplification-as-a-secondary-oncogenic-driver2026-07-07https://itsupport.concertai.com/testing-dynamic-2/rapid-and-deep-prostate-specific-antigen-psa-response-to-apalutamide-plus-adt-and-survival-in-metastatic-castration-sensitive-prostate-cancer-mcspc-in-real-world2026-07-07https://itsupport.concertai.com/testing-dynamic-2/machine-learning-model-to-forecast-patient-availability-for-oncology-clinical-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/outcomes-for-patients-with-chronic-lymphocytic-leukemia-cll-previously-treated-with-both-a-covalent-btk-and-bcl2-inhibitor-in-the-united-states-a-real-world-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/chasm-between-cancer-quality-measures-and-electronic-health-record-data-quality2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-trends-with-immune-checkpoint-inhibitor-ici-therapy-in-older-adults-with-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-outcomes-among-patients-with-egfr-mutant-advanced-nsclc-in-the-frontline-and-post-osimertinib-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-big-data-strengths-and-weaknesses-of-asco-s-cancerlinq-discovery-multiple-myeloma-dataset2026-07-07https://itsupport.concertai.com/testing-dynamic-2/early-stage-unfavorable-hodgkin-lymphoma-patient-characteristics-in-real-world-oncology-data-from-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-friends-of-cancer-research-real-world-data-rwd-collaboration-pilot-2-0-methodological-recommendations-from-oncology-case-studies2026-07-07https://itsupport.concertai.com/testing-dynamic-2/co210-real-world-effectiveness-and-treatment-patterns-of-venetoclax-based-regimens-among-patients-with-chronic-lymphocytic-leukemia-cll-treated-in-community-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-clinical-outcomes-stratified-by-age-in-women-with-hr-plus-her2-advanced-metastatic-breast-cancer-receiving-palbociclib-combination2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-healthcare-resource-utilization-and-cost-among-relapsed-refractory-classical-hodgkins-lymphoma-patients-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identifying-the-genetic-basis-for-resistance-to-aromatase-inhibitors-ais-in-metastatic-breast-cancer-mbc-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/mild-or-moderate-adverse-events-aes-and-their-management-in-patients-receiving-immune-checkpoint-inhibitors-icis-for-advanced-metastatic-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-outcomes-of-apa-as-a-starting-treatment-impact-in-real-world-patients-with-mcspc-oasis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pediatric-cancer-in-the-united-states-a-comparison-of-three-data-sources2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-of-patients-with-brca-mutated-human-epidermal-growth-factor-receptor-2-her2-negative-metastatic-breast-cancer-a-cancerlinq-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/935p-demographics-clinical-characteristics-treatment-patterns-and-clinical-outcomes-of-patients-with-stages-i-iii-resected-nsclc-without-known-egfr-mutations2026-07-07https://itsupport.concertai.com/testing-dynamic-2/calibrating-observational-health-record-data-against-a-randomized-trial2026-07-07https://itsupport.concertai.com/testing-dynamic-2/long-term-survival-outcomes-in-nsclc-patients-with-targeted-therapy-and-immunotherapy-an-iaslc-analysis-of-asco-cancerlinq-discovery-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/ai-enabled-clinical-trial-framework-for-end-to-end-site-recommendation-and-enrollment-projection2026-07-07https://itsupport.concertai.com/testing-dynamic-2/testing-and-treatment-patterns-in-her2-plus-breast-cancer-patients-in-the-adjuvant-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-among-patients-with-non-squamous-advanced-non-small-cell-lung-cancer-ansclc-treated-with-docetaxel-based-regimens-post-initial-standard-of2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-of-adjuvant-endocrine-therapy-and-ovarian-suppression-in-premenopausal-hr-plus-her2-plus-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/p2-06-18-computational-modeling-of-comprehensive-genomic-profiling-to-predict-chemotherapy-benefit-in-advanced-nsclc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/supporting-the-use-of-rwd-in-oncology-drug-development-session-1-establishing-a-framework-for-evaluating-real-world-response2026-07-07https://itsupport.concertai.com/testing-dynamic-2/demographic-and-clinical-characteristics-of-advanced-ovarian-cancer-patients-treated-with-bevacizumab-in-real-world-oncology-clinics-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/characteristics-of-patients-receiving-immune-checkpoint-inhibitors-ici-in-ascos-cancerlinq2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identification-of-predictive-subphenotypes-for-clinical-outcomes-using-real-world-data-and-machine-learning2026-07-07https://itsupport.concertai.com/testing-dynamic-2/kras-co-mutational-landscape-dictates-treatment-outcomes-in-pancreatic-cancer-pc-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/ep-12a-03-overall-survival-after-treatment-with-first-line-osimertinib-for-egfr-mutant-advanced-nsclc-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-outcomes-of-patients-with-metastatic-nonsquamous-non-small-cell-lung-cancer-after-progression-on-standard-of-care-therapy-in-the2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-response-endpoints-in-patients-with-mnsclc-treated-with-chemotherapy-across-real-world-datasets2026-07-07https://itsupport.concertai.com/testing-dynamic-2/1231-unlocking-insights-lesson-learned-from-the-tokenization-of-a-psoriasis-trial2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-value-of-integrating-multi-care-settings-real-world-data-for-understanding-prostate-cancer-management2026-07-07https://itsupport.concertai.com/testing-dynamic-2/biomarker-prevalence-in-us-patients-with-gastric-gastroesophageal-junction-adenocarcinoma-gea-from-real-world-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-healthcare-resource-utilization-and-patient-reported-outcomes-for-patients-diagnosed-with-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/progression-free-survival-and-overall-survival-in-advanced-squamous-cell-carcinoma-of-head-and-neck-scchn-retrospective-analysis-of-a-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-and-clinical-outcomes-in-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-olaparib-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/progression-free-survival-in-advanced-head-and-neck-cancer-retrospective-analysis-of-a-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-characteristics-treatment-patterns-and-factors-of-biomarker-testing-among-patients-with-advanced-non-small-cell-lung-cancer-ansclc-in-the-us-2012-20202026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-use-of-accelerated-approval-oncology-drugs-subsequently-withdrawn-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/overall-survival-os-in-advanced-non-small-cell-lung-cancer-ansclc-patients-treated-with-frontline-chemotherapy-or-immunotherapy-by-comorbidity-a-real-world-data-rwd2026-07-07https://itsupport.concertai.com/testing-dynamic-2/disparities-in-genetic-testing-patterns-and-positivity-among-patients-with-breast-cancer-in-the-cancerlinq-real-world-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/irinotecan-is-associated-with-greater-symptom-burden-than-oxaliplatin-in-metastatic-colorectal-cancer-patients-mcrc-in-community-oncology2026-07-07https://itsupport.concertai.com/testing-dynamic-2/disparities-in-timely-treatment-among-lung-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/predicting-cardiac-adverse-events-in-patients-receiving-immune-checkpoint-inhibitors-a-machine-learning-approach-20202026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-sequencing-in-patients-with-locally-advanced-or-metastatic-urothelial-cancer-la-muc-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-in-the-real-world-a-national-analysis-of-patients-treated-for-early-stage-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/evaluating-the-impact-of-performance-status-criteria-on-minority-eligibility-for-oncology-clinical-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/considerations-in-the-use-of-secondary-data-sources-for-oncology-research2026-07-07https://itsupport.concertai.com/testing-dynamic-2/66p-egfr-testing-patterns-and-survival-in-stage-iiii-non-small-cell-lung-cancer-nsclc-analysis-using-the-cancerlinq-discovery-clqd-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-conditional-survival-analysis-of-patients-with-relapsed-refractory-classical-hodgkins-lymphoma-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/goserelin-3-month-depot-shows-non-inferiority-to-the-monthly-formulation-in-u-s-patients-with-premenopausal-breast-cancer-a-real-world-evidence-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/impact-of-disease-progression-on-patient-reported-outcomes-in-advanced-nsclc-evidence-from-patients-treated-in-real-world-community-oncology-settings2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-reported-outcomes-among-those-taking-pazopanib-for-metastatic-renal-cell-carcinoma-mrcc-in-a-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/characterization-of-clinical-symptoms-by-race-among-women-with-early-stage-hormone-receptor-positive-breast-cancer-before-starting-chemotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/non-interventional-cohort-study-on-patients-with-advanced-non-small-cell-lung-cancer-harboring-met-exon-14-skipping-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/rwd116-training-and-validation-of-caraai-a-multi-llm-platform-and-data-model-to-address-oncology-specific-challenges-in-clinical-data-extraction2026-07-07https://itsupport.concertai.com/testing-dynamic-2/using-an-epro-tool-to-help-meet-quality-metric-reporting-standards-screening-for-tobacco-usage-and-falls2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-relation-of-trouble-sleeping-depressed-mood-pain-and-fatigue-in-patients-with-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/p572-real-world-management-and-outcomes-for-newly-diagnosed-aml-patients-initiating-venetoclax-and-hypomethylating-agents-in-us-community-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-homologous-recombination-repair-mutation-hrrm-testing-patterns-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-treated-with-olaparib2026-07-07https://itsupport.concertai.com/testing-dynamic-2/maximizing-the-utility-of-real-world-evidence-integration-of-structured-emr-data-unstructured-emr-data-and-billing-data-for-economics-and-outcomes-research-in-oncology2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comparison-of-outcomes-for-patients-pts-with-r-r-chronic-lymphocytic-leukemia-cll-small-lymphocytic-lymphoma-sll-previously-treated-with-bruton-tyrosine-kinase2026-07-07https://itsupport.concertai.com/testing-dynamic-2/feasibility-and-acceptability-to-patients-of-a-longitudinal-system-for-evaluating-cancer-related-symptoms-and-quality-of-life-pilot-study-of-an-e-tablet-data-collection2026-07-07https://itsupport.concertai.com/testing-dynamic-2/disparities-in-patients-with-her2-positive-breast-cancer-receiving-optimal-treatment-analysis-of-the-real-world-asco-cancerlinq-dataset2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identification-of-biomarkers-for-early-progression-in-muscle-invasive-bladder-cancer-mibc-using-real-world-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/characteristics-treatment-patterns-and-outcomes-in-patients-with-high-risk-locally-advanced-cervical-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a-machine-learning-model-to-facilitate-patient-level-risk-screening-in-myelodysplastic-syndromes-mds-patients-in-routine-clinical-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/psa-nadir-stratified-outcomes-of-arpi-doublet-and-docetaxel-triplet-therapy-in-metastatic-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/evaluation-of-treatment-strategies-for-patients-with-stage-iiia-non-small-cell-lung-cancer-in-the-immunotherapy-era-20232026-07-07https://itsupport.concertai.com/testing-dynamic-2/relation-of-sleep-disturbance-depression-pain-and-fatigue-in-patients-with-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/435-identifying-the-period-of-heightened-risk-for-adrenal-insufficiency-in-patients-with-advanced-non-small-cell-lung-cancer-treated-with-first-line-immune-checkpoint2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-characteristics-treatment-modifications-and-outcomes-for-patients-with-acute-myeloid-leukemia-aml-receiving-hypomethylating-agents-hma-plus-venetoclax-ven-as2026-07-07https://itsupport.concertai.com/testing-dynamic-2/disproportionate-impact-of-covid-19-disease-among-racial-and-ethnic-minorities-in-the-u-s-cancer-population-as-seen-in-cancerlinq-discovery-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-overall-survival-using-oncology-electronic-health-record-data-friends-of-cancer-research-pilot2026-07-07https://itsupport.concertai.com/testing-dynamic-2/algorithm-to-derive-progression-based-lines-of-therapy-from-a-real-world-non-small-cell-lung-cancer-nsclc-dataset2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-association-of-skin-rash-severity-with-overall-survival-findings-from-patients-receiving-erlotinib-for-pancreatic-cancer-in-the-community-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/engagement-of-lung-cancer-patients-in-quality-of-life-assessments-administered-by-tablet-computer-as-a-routine-part-of-clinical-care2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-effect-of-disease-progression-on-patient-reported-outcomes-in-her-2-negative-metastatic-breast-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/analysis-of-the-psychological-impact-of-cancer-related-symptoms-on-patients-with-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-impact-of-adjuvant-chemotherapy-regimens-for-small-t1mi-a-b-node-negative-pn0-triple-negative-breast-cancer-tnbc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/a020-utilization-of-liquid-biopsy-in-metastatic-castrate-resistant-prostate-cancer-mcrpc-patient-characteristics-treatment-selection-and-mutational-status2026-07-07https://itsupport.concertai.com/testing-dynamic-2/245p-characteristics-of-real-world-rw-natalee-and-monarche-eligible-populations-a-us-electronic-health-records-ehr-database-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-effectiveness-of-met-inhibitors-versus-immunotherapy-plus-minus-chemotherapy-in-1l-for-patients-with-met-exon-14-skipping-mutations-in-non-small-cell-lung2026-07-07https://itsupport.concertai.com/testing-dynamic-2/1352p-real-world-second-line-outcomes-of-nsclc-patients-receiving-first-line-chemotherapy-plus-immunotherapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/characterizing-node-negative-non-small-cell-lung-cancer-patients-with-similarity-networks-a-cancerlinq-discovery-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/effect-of-brain-metastasis-on-patient-reported-outcomes-in-advanced-nsclc-treated-in-real-world-community-oncology-settings-20162026-07-07https://itsupport.concertai.com/testing-dynamic-2/6638-19-identifying-cancer-germline-variants-associated-with-patient-prognosis-and-response-by-applying-clinico-genomics-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/biomarker-testing-and-patterns-of-treatment-in-nsclc-patients-an-iaslc-analysis-of-asco-cancerlinq-discovery-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-symptom-burden-and-early-treatment-discontinuation-in-1st-line-metastatic-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/reaching-beyond-maximum-grade-progress-and-future-directions-for-modernising-the-assessment-and-reporting-of-adverse-events-in-haematological-malignancies2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-risk-of-recurrence-and-treatment-outcomes-with-adjuvant-endocrine-therapy-in-patients-with-stage-ii-iii-hr-plus-her2-early-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/cost-and-healthcare-resource-utilization-hcru-for-patients-receiving-neoadjuvant-therapy-for-early-stage-triple-negative-breast-cancer-estnbc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/optimizing-the-identification-and-classification-of-non-small-cell-lung-cancer-nsclc-validation-and-implementation-of-a-patient-cohort-algorithm-in-claims-databases2026-07-07https://itsupport.concertai.com/testing-dynamic-2/low-rates-of-brca1-and-brca2-testing-for-patients-with-ovarian-cancer-in-asco-s-cancerlinq-a-real-world-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/machine-learning-ml-on-real-world-data-rwd-of-front-line-1l-metastatic-castration-resistance-prostate-cancer-mcrpc-patients-for-dynamic-prediction-of-time-to-tx2026-07-07https://itsupport.concertai.com/testing-dynamic-2/957-machine-learning-ml-model-for-prediction-of-pneumonitis-using-real-world-data-rwd-on-immune-checkpoint-inhibitor-ici-treated-advanced-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/338p-leveraging-nsclc-foundation-models-to-predict-biomarker-testing-pattern2026-07-07https://itsupport.concertai.com/testing-dynamic-2/trends-in-biomarker-testing-among-advanced-nsclc-patients-in-oncology-practice-settings-in-the-us2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-trial-participants-with-metastatic-renal-cell-carcinoma-differ-from-patients-treated-in-real-world-practice2026-07-07https://itsupport.concertai.com/testing-dynamic-2/exploration-of-real-world-outcomes-in-patients-with-previously-treated-hr-plus-her2-and-triple-negative-metastatic-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-characteristics-treatment-patterns-and-clinical-outcomes-in-us-patients-with-stage-i-iii-resected-nsclc-without-known-egfr-mutations-the-resect-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/15-real-world-evidence-shows-no-survival-advantage-with-contemporary-first-line-strategies-in-papillary-renal-cell-carcinoma-a-call-for-randomized-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/care-at-the-end-of-life-during-the-covid-19-pandemic-a-cancerlinq-discovery-clqd-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/adverse-events-and-clinical-outcomes-in-patients-treated-with-pd-l-1-blockade-for-advanced-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/association-of-clinical-trial-enrollment-and-mortality-amongst-patients-with-advanced-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/racial-disparities-in-newly-diagnosed-hematological-malignancies-in-the-united-states-during-the-covid-19-pandemic-january-2020-to-march-20212026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-outcomes-in-metastatic-renal-cell-carcinoma-insights-from-a-joint-community-academic-registry2026-07-07https://itsupport.concertai.com/testing-dynamic-2/773-evaluating-clinical-features-and-prognostic-factors-associated-with-response-to-immune-checkpoint-blockade-in-mnsclc-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comparative-analysis-of-different-methods-of-disease-progression-data-capture-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patterns-of-concurrent-chemotherapy-selection-in-us-patients-undergoing-trimodality-therapy-for-muscle-invasive-bladder-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/development-of-a-prognostic-factor-index-among-women-with-hr-plus-her2-metastatic-breast-cancer-in-a-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identifying-co-mutational-signatures-in-stk11-mutated-advanced-non-small-cell-lung-cancer-ansclc-patients-that-help-overcome-poor-response-to-immune-checkpoint2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-trial-subjects-compared-to-patients-treated-in-real-world-practice-generalizability-of-renal-cell-carcinoma-trials2026-07-07https://itsupport.concertai.com/testing-dynamic-2/predicting-progression-free-survival-pfs-in-first-line-1l-immune-checkpoint-inhibitor-ici-treated-patients-pts-with-advanced-non-small-cell-lung-cancer-ansclc-machine2026-07-07https://itsupport.concertai.com/testing-dynamic-2/retrospective-electronic-medical-records-study-of-treatment-patterns-among-cll-patients-in-the-cancerlinq-research-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-overall-survival-os-and-disease-free-survival-dfs-in-early-stage-non-small-cell-lung-cancer-nsclc-following-complete-resection2026-07-07https://itsupport.concertai.com/testing-dynamic-2/outcomes-for-patients-with-mantle-cell-lymphoma-post-covalent-btk-inhibitor-therapy-in-the-united-states-and-japan-a-study-of-two-real-world-databases2026-07-07https://itsupport.concertai.com/testing-dynamic-2/demographics-and-clinical-characteristics-of-metastatic-colorectal-cancer-patients-treated-with-a-biosimilar-to-bevacizumab2026-07-07https://itsupport.concertai.com/testing-dynamic-2/augmentation-of-real-world-mortality-data-in-the-electronic-medical-record-assessing-the-impact-on-overall-survival-estimates-in-multiple-myeloma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/5351-19-epidemiology-of-folate-receptor-alpha-expression-in-ovarian-cancer-by-age-race-ethnicity-and-histotype-in-a-real-world-us-based-clinicogenomic-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-progression-free-survival-by-timing-of-molecular-profiling-testing-among-metastatic-non-small-cell-lung-cancer-patients-in-a-community-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/outcomes-among-patients-with-mantle-cell-lymphoma-post-covalent-btk-inhibitor-therapy-in-the-united-states-a-real-world-electronic-medical-records-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/assessing-feasibility-of-using-rwd-to-support-biosimilar-development-rituximab-use-in-us-patients-with-follicular-lymphoma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-clinical-characteristics-of-patients-with-advanced-basal-cell-carcinoma-in-the-community-oncology-setting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-of-trifluridine-tipiracil-monotherapy-ftd-tpi-and-ftd-tpi-plus-bevacizumab-combination-therapy-ftd-tpi-plus-bev-in-639-black-patients-pts2026-07-07https://itsupport.concertai.com/testing-dynamic-2/adverse-events-among-patient-treated-for-metastatic-renal-cell-carcinoma-mrcc-data-from-a-real-world-multicenter-registry2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-profiles-treatment-patterns-and-outcomes-among-persistent-recurrent-or-metastatic-cervical-cancer-patients-under-routine-care-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/pp01-95-real-world-egfr-testing-and-adjuvant-treatment-patterns-among-patients-with-resected-early-stage-non-small-cell-lung-cancer-nsclc-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/improving-health-care-efficiency-and-quality-using-tablet-personal-computers-to-collect-research-quality-patient-reported-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identifying-genetic-factors-of-response-and-resistance-to-cdk4-6-inhibitors-in-metastatic-hr-plus-her2-breast-cancer-using-real-world-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/development-of-an-artificial-intelligence-model-to-predict-survival-at-specific-time-intervals-for-lung-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/burden-of-symptoms-associated-with-development-of-metastatic-bone-disease-in-patients-with-breast-cancer-20132026-07-07https://itsupport.concertai.com/testing-dynamic-2/effectiveness-outcomes-in-patients-with-advanced-nsclc-treated-in-real-world-community-oncology-settings-results-from-a-prospective-medical-record-registry-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/an-emulation-of-the-keynote-189-trial-using-electronic-health-records2026-07-07https://itsupport.concertai.com/testing-dynamic-2/leveraging-large-language-models-to-drive-efficiency-in-clinical-trial-simulation2026-07-07https://itsupport.concertai.com/testing-dynamic-2/biomarkers-of-response-in-patients-with-gastric-gastroesophageal-junction-adenocarcinoma-gea-treated-with-telisotuzumab-adizutecan2026-07-07https://itsupport.concertai.com/testing-dynamic-2/outcomes-of-real-world-treatment-for-metastatic-renal-cell-carcinoma-mrcc2026-07-07https://itsupport.concertai.com/testing-dynamic-2/comorbidity-assessment-using-integrated-ehr-and-claims-in-a-national-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/4623-mutations-in-the-bruton-tyrosine-kinase-btk-gene-in-patients-with-chronic-lymphocytic-leukemia-cll-receiving-btk-inhibitors-btkis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-of-patients-with-brca-mutated-brcam-her2-negative-metastatic-breast-cancer-a-cancerlinq-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/luminate-102-a-real-world-study-on-biomarker-testing-rates-among-patients-with-non-small-cell-lung-cancer-nsclc-across-lines-of-therapy2026-07-07https://itsupport.concertai.com/testing-dynamic-2/treatment-patterns-and-health-resource-utilization-among-patients-diagnosed-with-early-stage-resected-non-small-cell-lung-cancer-at-us-community-oncology-practices2026-07-07https://itsupport.concertai.com/testing-dynamic-2/identifying-genetic-factors-for-resistance-and-response-to-immune-checkpoint-inhibitors-icis-in-advanced-non-small-cell-lung-cancer-ansclc-patients-using-real-world-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/risk-of-death-before-and-after-metastasis-in-high-risk-localized-and-locally-advanced-prostate-cancer-patients-undergoing-radical-prostatectomy-or-radiotherapy-as2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-clinical-outcomes-of-patients-pts-with-metastatic-colorectal-cancer-mcrc-who-received-trifluridine-tipiracil-ftd-tpi-monotherapy-or-ftd-tpi-plus-bevacizumab2026-07-07https://itsupport.concertai.com/testing-dynamic-2/269-impact-of-ibrutinib-dose-reduction-on-duration-of-therapy-in-patients-with-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-relationship-between-treatment-intensity-and-characteristics-of-patients-with-early-stage-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/patient-characteristics-and-costs-in-recurrent-or-refractory-head-and-neck-cancer-retrospective-analysis-of-a-community-oncology-database2026-07-07https://itsupport.concertai.com/testing-dynamic-2/survival-of-patients-with-multiple-myeloma-diagnosed-with-second-primary-malignancies-an-asco-cancerlinq-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/molecular-testing-and-patterns-of-treatment-in-nsclc-patients-an-iaslc-analysis-of-asco-cancerlinq-discovery-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-patient-profiles-treatment-patterns-and-outcomes-among-recurrent-persistent-and-metastatic-cervical-cancer-patients2026-07-07https://itsupport.concertai.com/testing-dynamic-2/retrospective-electronic-health-records-study-in-the-cancerlinq-discovery-database-of-treatment-patterns-among-patients-with-chronic-lymphocytic-leukemia2026-07-07https://itsupport.concertai.com/testing-dynamic-2/implementing-a-braf-biomarker-electronic-clinical-quality-measure-in-cancerlinq2026-07-07https://itsupport.concertai.com/testing-dynamic-2/cancer-patient-perspectives-on-sharing-of-medical-records-and-mobile-device-data-for-research-purposes2026-07-07https://itsupport.concertai.com/testing-dynamic-2/symptom-burden-in-patients-with-follicular-lymphoma-undergoing-maintenance-treatment-with-rituxan-compared-with-observation2026-07-07https://itsupport.concertai.com/testing-dynamic-2/willingness-to-pay-to-prevent-chemotherapy-induced-nausea-and-vomiting2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-and-outcomes-for-egfr-wt-advanced-metastatic-non-squamous-non-small-cell-lung-cancer-pooled-analysis-from-project-luminate-1012026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-outcomes-of-daratumumab-retreatment-in-multiple-myeloma-in-the-united-states2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-effectiveness-outcomes-in-patients-with-early-stage-triple-negative-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/clinical-outcomes-among-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc-who-received-immune-checkpoint-inhibitors-ici-in-first-1l-and-second-line-2l2026-07-07https://itsupport.concertai.com/testing-dynamic-2/demographics-clinical-characteristics-and-treatment-patterns-for-patients-with-brca-mutated-her2-negative-early-stage-breast-cancer-a-cancerlinq-real-world-us-study2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-study-on-the-characteristics-post-nephrectomy-journey-and-outcomes-of-patients-with-early-stage-renal-cell-carcinoma-based-on-risk-groups2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-study-on-characteristics-post-nephrectomy-journey-and-outcomes-of-patients-with-early-stage-renal-cell-carcinoma-based-on-risk-groups2026-07-07https://itsupport.concertai.com/testing-dynamic-2/impact-of-real-world-response-to-first-line-immunotherapy-and-chemotherapy-on-subsequent-treatment-outcomes-in-patients-with-advanced-or-metastatic-non-small-cell-lung2026-07-07https://itsupport.concertai.com/testing-dynamic-2/trifluridine-tipiracil-with-and-without-bevacizumab-in-colorectal-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/eph131-estimating-us-cancer-prevalence-with-community-oncology-ehr-based-datasets-via-national-benchmarks-from-seer-and-npcr2026-07-07https://itsupport.concertai.com/testing-dynamic-2/emulating-comparative-oncology-trials-with-real-world-evidence-studies-encore-process-development-and-methodological-considerations-for-oncology-real-world-data2026-07-07https://itsupport.concertai.com/testing-dynamic-2/the-friends-of-cancer-research-real-world-data-rwd-pilot-2-0-collaboration-implementation-of-standardized-methodological-approaches-for-evaluation-of-oncology-rwd2026-07-07https://itsupport.concertai.com/testing-dynamic-2/quantification-of-information-gained-by-linking-claims-data-to-an-electronic-health-record-cohort-of-patients-with-metastatic-breast-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/relationship-between-incidence-of-fracture-and-health-related-quality-of-life-in-metastatic-breast-cancer-patients-with-bone-metastases2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-treatment-patterns-and-effectiveness-among-patients-with-metastatic-colorectal-cancer-treated-with-ziv-aflibercept-in-community-oncology-practices-in-the-usa2026-07-07https://itsupport.concertai.com/testing-dynamic-2/amivantamab-compared-with-real-world-therapies-in-patients-with-advanced-non-small-cell-lung-cancer-harboring-egfr-exon-20-insertion-mutations-who-progressed-after2026-07-07https://itsupport.concertai.com/testing-dynamic-2/19p-mortality-among-egfr-mutated-advanced-nsclc-patients-after-frontline-osimertinib-treatment-a-real-world-us-attrition-analysis2026-07-07https://itsupport.concertai.com/testing-dynamic-2/real-world-characteristics-and-outcomes-of-patients-with-advanced-non-small-cell-lung-cancer-ansclc-receiving-immune-checkpoint-inhibitor2026-07-07https://itsupport.concertai.com/testing-dynamic-2/assessment-of-electronic-health-record-ehr-based-machine-learning-ml-in-predicting-risk-of-brain-metastasis-among-patients-with-early-stage-non-small-cell-lung-cancer2026-07-07https://itsupport.concertai.com/testing-dynamic-2/biomarker-testing-and-treatment-patterns-in-us-patients-pts-with-advanced-metastatic-nonsmall-cell-lung-cancer-nsclc-harboring-met-amplification2026-07-07